Pain control and functional improvement in patients treated by autologous conditioned serum after failure of platelet rich plasma treatments in knee osteoarthritis.
Rosa LeoneAlessandro de RosaPaola IudiconeDaniela FioravantiGiuseppe CapuaFrancesca RossettiMaria Antonietta Isgro'Luca PierelliPublished in: Transfusion medicine (Oxford, England) (2021)
The present study confirms the efficacy of ACS in pain control and functional recovery of patients with knee osteoarthritis resistant to medical and PRP treatment. These results were obtained in a well-defined cohort of resistant patients and seem to be related with IL1-RA content in injected ACS.
Keyphrases
- knee osteoarthritis
- platelet rich plasma
- chronic pain
- acute coronary syndrome
- end stage renal disease
- pain management
- ejection fraction
- neuropathic pain
- chronic kidney disease
- healthcare
- newly diagnosed
- peritoneal dialysis
- rheumatoid arthritis
- stem cells
- spinal cord injury
- systemic lupus erythematosus
- mesenchymal stem cells
- patient reported outcomes
- systemic sclerosis
- disease activity
- combination therapy
- smoking cessation